Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Taysha Gene Therapies Inc

Taysha Gene Therapies Inc

TSHA · NASDAQ
TSHA · NASDAQ

Next Earnings: 20 May 2026

5.18
USD-1.11-17.63%

Latest News

    @MarketRebels
    MarketRebels

    STARTS NOW! Rebel's Edge 1pm $TSHA $FICO $STLA $NFLX 🏈 NAJARIAN SPORTS 🏴‍☠️ with @petenajarian Eagles vs. Bills in the Super Bowl? Both teams undefeated and dominating! Dodgers sweep Reds 8-4, advance to NLDS led by Mookie Betts & Yamamoto! Yankees force Game 3 vs. BoSox with a https://t.co/vI157P5AJX

      @eWhispers
      eWhispers

      #earnings after the close https://t.co/lObOE0dgsr $LULU $MU $PLAY $CALM $IDEX $PRGS $SOL $JEF $NCNO $ARCT $DNMR $SFT $SLGC $TSHA $SSKN $ICAD $KITT $CRVS $ASM $BTMD $DMAC https://t.co/te1Buh0pJ2

        Financial Times

        TSHA: Capricorn Sun album review — imbued with warmth and a sense of connection - Financial Times

          @eWhispers
          eWhispers

          Monday morning #earnings https://t.co/lObOE0dgsr $CLSK $UWMC $PSFE $NIU $RAIL $DOYU $OEG $VBLT $DRIO $HHR $MLSS $ZH $HGE $VEI $AKU $PLX $LIQT $OTLY $ONDS $TSHA $YOU $VET $LRFC $IMPL $FRLN $CRKN $MINM $ATAI https://t.co/mnVOwZ6eB6

          Analysts Recommendations

          Bullish

          Buy

          Strong Buy

          Buy

          Hold

          Sell

          Strong Sell

          Day Range

          5.18USD
          5.50USD

          52 Week Range

          2.25USD
          7.30USD

          Market Cap

          1.71BUSD

          lock-imagelock-image

          Get Full Access with Profit PRO

          See which Billionaires own this investment

          About

          General Information

          Type

          Common Stock

          Exchange

          NASDAQ

          Currency Code

          USD

          Currency Name

          US Dollar

          Country Name

          USA

          Country ISO

          US

          ISIN

          US8776191061

          CUSIP

          877619106

          Sector

          Healthcare

          Industry

          Biotechnology

          Fiscal Year End

          December

          IPO date

          -

          Updated At

          -

          Highlights

          PE Ratio

          -

          PEG Ratio

          -

          Book Value

          0.87

          Dividend Share

          -

          Dividend Yield

          -

          Earnings Share

          -0.38

          Wall Street Target Price

          12.23

          EPS Estimate Current Year

          -0.44

          EPS Estimate Next Year

          -0.44

          EPS Estimate Current Quarter

          -0.098

          EPS Estimate Next Quarter

          -0.1025

          Most Recent Quarter

          -

          Profitability

          Revenue TTM

          7,471,000

          Gross Profit TTM

          7,471,000

          EBITDA

          -131,406,000

          Profit Margin

          0.00%

          Return On Assets TTM

          -37.77%

          Return On Equity TTM

          -97.28%

          Revenue Per Share TTM

          0.022

          Qtly Revenue Growth YOY

          171.30%

          Diluted Eps TTM

          -0.38

          Qtly Earnings Growth YOY

          0.00%

          Valuation

          Trailing PE

          0.00

          Forward PE

          0

          Price Sales TTM

          209.4339

          Price Book MRQ

          7.3825

          Enterprise Value Revenue

          181

          Enterprise Value EBITDA

          0

          Peers analysis

          • UCB SA
            UCBJFUCB SA

            283.89

            3.04%
          • UCB SA ADR
            UCBJYUCB SA ADR

            136.01

            1.42%
          • CSL Ltd
            CSLLYCSL Ltd

            17.40

            0.75%
          • Alnylam Pharmaceuticals Inc
            ALNYAlnylam Pharmaceuticals Inc

            294.30

            0.33%
          • argenx SE
            ARGNFargenx SE

            803.19

            0.00%
          • Regeneron Pharmaceuticals Inc
            REGNRegeneron Pharmaceuticals Inc

            630.30

            -11.57%
          • Vertex Pharmaceuticals Inc
            VRTXVertex Pharmaceuticals Inc

            434.31

            -3.61%
          • argenx NV ADR
            ARGXargenx NV ADR

            797.77

            -2.91%
          • Revolution Medicines Inc
            RVMDRevolution Medicines Inc

            147.30

            -1.49%
          • CSL Limited
            CMXHFCSL Limited

            68.51

            -0.71%
          XM

          Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

          Trade with a Trusted, Award-Winning Broker.

          Trading involves risk. The value of investments may go up or down. Trade responsibly.

          FAQs

          What is Taysha Gene Therapies Inc stock price today?

          What is Taysha Gene Therapies Inc stock ticker?

          Is TSHA stock price going up?

          What is the analyst recommendation for TSHA?

          What is TSHA market cap?

          Does TSHA release financial reports?

          When is TSHA next earnings date?

          What were TSHA Earnings for the last quarter?

          What was TSHA Revenue for the last quarter?

          What was TSHA Net Income for the last quarter?

          Does TSHA pay dividends?

          How many employees does TSHA have?

          What is TSHA EBITDA?

          How to buy TSHA stocks?

          Should I invest in TSHA stock?